PLoS computational biology 2015-03-01

Kinetically-defined component actions in gene repression.

Carson C Chow, Kelsey K Finn, Geoffery B Storchan, Xinping Lu, Xiaoyan Sheng, S Stoney Simons

文献索引:PLoS Comput. Biol. 11(3) , e1004122, (2015)

全文:HTML全文

摘要

Gene repression by transcription factors, and glucocorticoid receptors (GR) in particular, is a critical, but poorly understood, physiological response. Among the many unresolved questions is the difference between GR regulated induction and repression, and whether transcription cofactor action is the same in both. Because activity classifications based on changes in gene product level are mechanistically uninformative, we present a theory for gene repression in which the mechanisms of factor action are defined kinetically and are consistent for both gene repression and induction. The theory is generally applicable and amenable to predictions if the dose-response curve for gene repression is non-cooperative with a unit Hill coefficient, which is observed for GR-regulated repression of AP1LUC reporter induction by phorbol myristate acetate. The theory predicts the mechanism of GR and cofactors, and where they act with respect to each other, based on how each cofactor alters the plots of various kinetic parameters vs. cofactor. We show that the kinetically-defined mechanism of action of each of four factors (reporter gene, p160 coactivator TIF2, and two pharmaceuticals [NU6027 and phenanthroline]) is the same in GR-regulated repression and induction. What differs is the position of GR action. This insight should simplify clinical efforts to differentially modulate factor actions in gene induction vs. gene repression.


相关化合物

  • NU6027
  • 地塞米松
  • 12-O-十四烷酰佛波...
  • L-甲状腺素钠五水合...
  • 1,7-菲啰啉
  • 左旋甲状腺素

相关文献:

Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells.

2013-01-01

[PLoS ONE 8 , e57098, (2013)]

Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines.

2011-07-26

[Br. J. Cancer 105 , 372-81, (2011)]

HERC2/USP20 coordinates CHK1 activation by modulating CLASPIN stability.

2014-12-01

[Nucleic Acids Res. 42(21) , 13074-81, (2014)]

更多文献...